Client News

Andera Partners co-leads €105 million Series A round for Adcytherix, its first investment from the BioDiscovery 7 fund

TVM CAPITAL LIFE SCIENCE PORTFOLIO COMPANY SMART REPORTING TO ACQUIRE FLUENCY FOR IMAGING – UNITING TO CREATE JACOBIAN AND ACCELERATE AI-POWERED REPORTING

Actor Pharmaceuticals and Megalabs become partners for the commercialization of Formycon’s Eylea® biosimilar FYB203 (aflibercept) for Australia and Latin America

Mainz Biomed to Attend 2025 Maxim Growth Summit 

Andera Partners Reinvests in Tubulis’ €308 million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline

QUANTRO Therapeutics extends collaboration with Boehringer Ingelheim to address high unmet needs in cancer patients

Together We Build: Rentschler Biopharma celebrates construction progress of new buffer media facility, largest single investment at Laupheim site

Heidelberg Pharma Reports on the First Nine Months of Financial Year 2025

Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

Heidelberg Pharma AG Announces Updated Guidance